Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34109735

Cutaneous adverse events in children treated with vemurafenib for refractory BRAF(V600E) mutated Langerhans cell histiocytosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2021 Sep
First author
Tardieu M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Tardieu M
      type
      Author
    2. name
      Néron A
      type
      Author
    3. name
      Duvert-Lehembre S
      type
      Author
    4. name
      Amine Larabi I
      type
      Author
    5. name
      Barkaoui M
      type
      Author
    6. name
      Emile JF
      type
      Author
    7. name
      Seigneurin A
      type
      Author
    8. name
      Boralevi F
      type
      Author
    9. name
      Donadieu J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Tardieu M
      type
      Author
    2. name
      Néron A
      type
      Author
    3. name
      Duvert-Lehembre S
      type
      Author
    4. name
      Amine Larabi I
      type
      Author
    5. name
      Barkaoui M
      type
      Author
    6. name
      Emile JF
      type
      Author
    7. name
      Seigneurin A
      type
      Author
    8. name
      Boralevi F
      type
      Author
    9. name
      Donadieu J
      type
      Author
    bibliography ids
    1. nci-bib-57ca7598b399275243303f16
    book metadata
    content sha256
    3bf70fc23a8fda68fdf27f4f94fd4ada05221e40ddc507bb13f40c64692dd7a6
    document type
    citation
    dois
    1. 10.1002/pbc.29140
    electronic publication date
    display
    2021 Jun 9
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34109735
    immutable id
    pubmed:34109735@3bf70fc23a8fda68fdf27f4f94fd4ada05221e40ddc507bb13f40c64692dd7a6
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    9
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e29140
    volume
    68
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34109735
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      cfd9babbe63c0c73aa4441ca963fe7814ff57531b023cf3ee7bac4c5e70ca5f8
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Sep
      precision
      month
      year
      2021
      publication types
      1. Journal Article
      2. Observational Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34109735/
      title
      Cutaneous adverse events in children treated with vemurafenib for refractory BRAF(V600E) mutated Langerhans cell histiocytosis.

      Preserved source evidence · Not medical advice